Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Paolieri F"" wg kryterium: Autor


Wyświetlanie 1-6 z 6
Tytuł:
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs.
Autorzy:
Del Re M; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Crucitta S; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Paolieri F; Unit of Medical Oncology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Cucchiara F; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Verzoni E; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Bloise F; Unit of Medical Oncology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Ciampi R; Endocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Mercinelli C; Unit of Medical Oncology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Capuano A; Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Sportiello L; Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Martinetti A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Procopio G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Galli L; Unit of Medical Oncology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Porta C; Division of Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy.
Bracarda S; Unit of Medical and Translational Oncology, Department of Oncology, Civil Hospital of Terni, Terni, Italy.
Danesi R; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2022 Aug 16; Vol. 20 (1), pp. 371. Date of Electronic Publication: 2022 Aug 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cell-Free Nucleic Acids*/genetics
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/genetics
Biomarkers, Tumor/genetics ; Carcinoma, Renal Cell ; DNA ; Humans ; Immunotherapy ; Liquid Biopsy ; Prospective Studies ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Receptors, Vascular Endothelial Growth Factor ; Tumor Suppressor Protein p53/genetics ; Vascular Endothelial Growth Factor A
SCR Disease Name:
Clear-cell metastatic renal cell carcinoma
Czasopismo naukowe
Tytuł:
Compassionate Use Program of Ipilimumab and Nivolumab in Intermediate or Poor Risk Metastatic Renal Cell Carcinoma: A Large Multicenter Italian Study.
Autorzy:
Basso U; Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, 35128 Padova, Italy.
Paolieri F; Medical Oncology Unit 2, Azienda Ospedaliera Universitaria Pisana, 43126 Pisa, Italy.
Rizzo M; Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, 27100 Pavia, Italy.
De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, Italy.
Bracarda S; Medical and Translational Oncology Unit, Azienda Ospedaliera Santa Maria, 05100 Terni, Italy.
Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, 50135 Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.
Atzori F; Medical Oncology, Azienda Ospedaliero-Universitaria, 09124 Cagliari, Italy.
Cartenì G; Oncology Unit, Azienda Ospedaliera di Rilievo Nazionale 'Antonio Cardarelli'-AORN A. Cardarelli, 80131 Napoli, Italy.
Procopio G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Fratino L; Medical Oncology Unit, Centro di Riferimento Oncologico CRO IRCCS, 33081 Aviano (PN), Italy.
D'Arcangelo M; Department of Oncology and Hematology, Azienda Unità Sanitaria Locale della Romagna, 48121 Ravenna, Italy.
Fornarini G; Medical Oncology Unit 1, Ospedale Policlinico San Martino IRCCS, 16132 Genova, Italy.
Zucali P; Department of Biomedical Sciences, Humanitas University, 20090 Milan, Italy.; Department of Oncology, IRCCS Humanitas Research Hospital, 20089 Milan, Italy.
Cusmai A; Don Tonino Bello Oncology, Istituto Tumori IRCCS Giovanni Paolo II, 70124 Bari, Italy.
Santoni M; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
Pipitone S; Department of Oncology and Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero Universitaria of Modena, 41125 Modena, Italy.
Carella C; Medical Oncology Unit, Istituto Tumori IRCCS Giovanni Paolo II, 70124 Bari, Italy.
Panni S; Medical Oncology Unit, ASST di Cremona, 26100 Cremona, Italy.
Deppieri FM; Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, 35128 Padova, Italy.
Zagonel V; Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, 35128 Padova, Italy.
Tortora G; Università Cattolica del Sacro Cuore, 00168 Rome, Italy.; Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, 00168 Rome, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 May 04; Vol. 14 (9). Date of Electronic Publication: 2022 May 04.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Clinical and economic effect of administration of red blood product transfusions in an outpatient supportive care cancer service.
Autorzy:
Sbrana A; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, I-56126 Pisa, Italy.
Paolieri F; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, I-56126 Pisa, Italy.
Bloise F; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, I-56126 Pisa, Italy.
Danova M; Internal Medicine and Medical Oncology, AZIENDA Socio-Sanitaria Territoriale di Pavia, I-27100 Pavia, Italy.
Galli L; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, I-56126 Pisa, Italy.
Brunetti IM; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, I-56126 Pisa, Italy.
Vasile E; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, I-56126 Pisa, Italy.
Ricci S; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, I-56126 Pisa, Italy.
Falcone A; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, I-56126 Pisa, Italy.
Antonuzzo A; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, I-56126 Pisa, Italy.
Pokaż więcej
Źródło:
Biomedical reports [Biomed Rep] 2020 Apr; Vol. 12 (4), pp. 199-203. Date of Electronic Publication: 2020 Feb 10.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Androgen receptor (AR) splice variant 7 and full-length AR expression is associated with clinical outcome: a translational study in patients with castrate-resistant prostate cancer.
Autorzy:
Del Re M; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Crucitta S; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Sbrana A; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Rofi E; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Paolieri F; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Gianfilippo G; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Galli L; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Falcone A; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Morganti R; Section of Statistics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Porta C; Department of Internal Medicine, University of Pavia, Pavia, Italy.; Division of Translational Oncology, I.R.C.C.S. Istituti Clinici Scientifici Maugeri, Pavia, Italy.
Efstathiou E; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
van Schaik R; Department of Clinical Chemistry, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Jenster G; Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Danesi R; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2019 Oct; Vol. 124 (4), pp. 693-700.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro.
Autorzy:
Buscaglia S; Department of Internal Medicine, DIMI, University of Genoa, Italy.
Paolieri F
Catrullo A
Fiorino N
Riccio AM
Pesce G
Montagna P
Bagnasco M
Ciprandi G
Canonica GW
Pokaż więcej
Źródło:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 1996 Oct; Vol. 26 (10), pp. 1188-96.
Typ publikacji:
Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Eye/*drug effects
Eye/*metabolism
Intercellular Adhesion Molecule-1/*biosynthesis
Intercellular Adhesion Molecule-1/*drug effects
Piperidines/*administration & dosage
Piperidines/*therapeutic use
Acute-Phase Reaction/drug therapy ; Administration, Topical ; Adolescent ; Adult ; Cells, Cultured ; Cross-Over Studies ; Double-Blind Method ; Drug Administration Routes ; Epithelium/drug effects ; Epithelium/metabolism ; Female ; Humans ; Hypersensitivity, Delayed/drug therapy ; Male ; Middle Aged
Czasopismo naukowe
Tytuł:
Expression of CD56 (NKH-1) differentiation antigen in human thyroid epithelium.
Autorzy:
Zeromski J; Department of Immunopathology, University Medical School, Poznan, Poland.
Bagnasco M
Paolieri F
Dworacki G
Pokaż więcej
Źródło:
Clinical and experimental immunology [Clin Exp Immunol] 1992 Sep; Vol. 89 (3), pp. 474-8.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigens, CD/*physiology
Antigens, Differentiation, T-Lymphocyte/*physiology
Thyroid Gland/*immunology
Antibodies, Monoclonal ; Antigens, CD/analysis ; Antigens, Differentiation, T-Lymphocyte/analysis ; CD56 Antigen ; Humans ; Immunohistochemistry ; Thyroid Gland/chemistry
Czasopismo naukowe
    Wyświetlanie 1-6 z 6

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies